MARKET

VRML

VRML

Vermillion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6349
+0.0149
+2.40%
Closed 16:00 09/13 EDT
OPEN
0.6439
PREV CLOSE
0.6200
HIGH
0.6439
LOW
0.6012
VOLUME
119.86K
TURNOVER
--
52 WEEK HIGH
1.570
52 WEEK LOW
0.2701
MARKET CAP
61.71M
P/E (TTM)
-3.5589
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VRML and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VRML News

  • Vermillion Highlights 2 Independent Publications Showing OVA1 Demonstrates Improved Ovarian Malignancy Risk Detection In African-American Women
  • Benzinga.09/04 12:08
  • Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women
  • Business Wire.09/04 12:00
  • Edited Transcript of VRML earnings conference call or presentation 8-Aug-19 8:30pm GMT
  • Thomson Reuters StreetEvents.09/02 04:10
  • Cramer's lightning round: Financial stocks are off limits until the yield curve improves
  • CNBC.com.08/26 23:50

More

Industry

Biotechnology & Medical Research
+0.20%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Name
Price
%Change

About VRML

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.
More

Webull offers Vermillion, Inc. (VRML) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.